US2018237867A1PendingUtilityA1
Methylation Biomarkers for Breast Cancer
Assignee: UNIV KING ABDULLAH SCI & TECHPriority: Jun 13, 2012Filed: Apr 25, 2018Published: Aug 23, 2018
Est. expiryJun 13, 2032(~5.8 yrs left)· nominal 20-yr term from priority
C12Q 1/6886C12Q 2600/154C12Q 2600/172
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Different combinations of methylation status based biomarkers can be used to test for breast cancer with high sensitivity and high specificity.
Claims
exact text as granted — not AI-modified1 . A highly specific and highly selective method of detecting breast cancer in a patient, comprising:
obtaining a DNA sample from the patient; and measuring, from the DNA sample, a methylation level in a regulatory region of each gene in a plurality of genes selected from the group consisting of: FOXC1, ARFGEF1, CREBBP, MSH6, ARHGEF7, GNG4, RPIA, SLC2A14, BTG3, EDNRB, PRDM16, SST, HS3ST2, ITGA9, CDH1, Hoxa7, BMP6, CD40, and TNFRSF8.
2 . The method of claim 1 , further comprising comparing the measured methylation level for each of the plurality of genes to a respective threshold methylation level, and, based on the comparisons, detecting the presence or absence of breast cancer in the patient with high sensitivity and high specificity.
3 . The method of claim 1 , wherein the plurality of genes includes nine or more of the genes listed in claim 1 .
4 . The method of claim 1 , wherein the DNA sample is obtained from a body fluid, wherein the body fluid is blood, serum, plasma, saliva, urine, stool, tissue, or a combination thereof.
5 . The method of claim 1 , wherein the genes are the genes of BC Set 1: ARFGEF1, ARHGEF7, CD40, CDH1, CREBBP, HS3ST2, RPIA, SST, and TNFRSF8.
6 . The method of claim 1 , wherein the genes are the genes of BC Set 2: ARFGEF1, ARHGE7, CD40, CDH1, HS3ST2, RPIA, SLC2A14, SST, and TNFRSF8.
7 . The method of claim 1 , wherein the genes are the genes of BC Set 3: ARFGEF1, ARHGE7, CDH1, CREBBP, HS3ST2, RPIA, SLC2A14, SST, and TNFRSF8.
8 . The method of claim 1 , wherein the genes are the genes of BC Set 4: ARFGEF1, CD40, CDH1, CREBBP, HS3ST2, RPIA, SLC2A14, SST, and TNFRSF8.
9 . The method of claim 1 , wherein the genes are the genes of BC Set 5: ARFGEF1, CDH1, CREBBP, HS3ST2, PRDM16, RPIA, SLC2A14, SST, and TNFRSF8.Join the waitlist — get patent alerts
Track US2018237867A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.